Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands

Imaging synaptic density in the living human brain

Finnema, S. J., Nabulsi, N. B., Eid, T., Detyniecki, K., Lin, S.-F., Chen, M.-K., Dhaher, R., Matuskey, D., Baum, E., Holden, D., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6667 · Cited by 575 · see citing works

Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers

Hirvonen, J., Goodwin, R. S., Li, C.-T., Terry, G. E., Zoghbi, S. S., Morse, C., Pike, V. W., Volkow, N. D., Huestis, M. A., & Innis, R. B. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.82 · Cited by 587 · see citing works

Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels

Madsen, M. K., Fisher, P. M., Burmester, D., Dyssegaard, A., Stenbæk, D. S., Kristiansen, S., Johansen, S. S., Lehel, S., Linnet, K., Svarer, C., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0324-9 · Cited by 517 · see citing works

Mesolimbic Functional Magnetic Resonance Imaging Activations during Reward Anticipation Correlate with Reward-Related Ventral Striatal Dopamine Release

Schott, B. H., Minuzzi, L., Krebs, R. M., Elmenhorst, D., Lang, M., Winz, O. H., Seidenbecher, C. I., Coenen, H. H., Heinze, H.-J., Zilles, K., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2058-08.2008 · Cited by 496 · see citing works

Deficits in Prefrontal Cortical and Extrastriatal Dopamine Release in Schizophrenia: A Positron Emission Tomographic Functional Magnetic Resonance Imaging Study

Slifstein, M., van de Giessen, E., Van Snellenberg, J., Thompson, J. L., Narendran, R., Gil, R., Hackett, E., Girgis, R., Ojeil, N., Moore, H., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2414 · Cited by 398 · see citing works

Striatal Dopamine D ₂ /D ₃ Receptor Availability Is Reduced in Methamphetamine Dependence and Is Linked to Impulsivity

Lee, B., London, E. D., Poldrack, R. A., Farahi, J., Nacca, A., Monterosso, J. R., Mumford, J. A., Bokarius, A. V., Dahlbom, M., Mukherjee, J., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3765-09.2009 · Cited by 374 · see citing works

Imaging robust microglial activation after lipopolysaccharide administration in humans with PET

Sandiego, C. M., Gallezot, J.-D., Pittman, B., Nabulsi, N., Lim, K., Lin, S.-F., Matuskey, D., Lee, J.-Y., O’Connor, K. C., Huang, Y., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511003112 · Cited by 356 · see citing works

Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: A positron emission tomography study

Neumeister, A., Normandin, M. D., Pietrzak, R. H., Piomelli, D., Zheng, M. Q., Gujarro-Anton, A., Potenza, M. N., Bailey, C. R., Lin, S. F., Najafzadeh, S., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.61 · Cited by 361 · see citing works

Elevated translocator protein in anterior cingulate in major depression and a role for inflammation in suicidal thinking: A positron emission tomography study

Holmes, S. E., Hinz, R., Conen, S., Gregory, C. J., Matthews, J. C., Anton-Rodriguez, J. M., Gerhard, A., & Talbot, P. S. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.08.005 · Cited by 346 · see citing works

The search for imaging biomarkers in psychiatric disorders

Abi-Dargham, A., & Horga, G. (2016) · Nature Medicine · doi:10.1038/nm.4190 · Cited by 311 · see citing works

In vivo measurement of widespread synaptic loss in Alzheimer’s disease with SV2A PET

Mecca, A. P., Chen, M., O'Dell, R. S., Naganawa, M., Toyonaga, T., Godek, T. A., Harris, J. E., Bartlett, H. H., Zhao, W., Nabulsi, N. B., et al. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12097 · Cited by 288 · see citing works

Reduced Metabotropic Glutamate Receptor 5 Density in Major Depression Determined by [¹¹C]ABP688 PET and Postmortem Study

Deschwanden, A., Karolewicz, B., Feyissa, A. M., Treyer, V., Ametamey, S. M., Johayem, A., Burger, C., Auberson, Y. P., Sovago, J., Stockmeier, C. A., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.09111607 · Cited by 278 · see citing works

Normative database of the serotonergic system in healthy subjects using multi-tracer PET

Savli, M., Bauer, A., Mitterhauser, M., Ding, Y.-S., Hahn, A., Kroll, T., Neumeister, A., Haeusler, D., Ungersboeck, J., Henry, S., et al. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.07.001 · Cited by 251 · see citing works

Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats

Onwordi, E. C., Halff, E. F., Whitehurst, T., Mansur, A., Cotel, M.-C., Wells, L., Creeney, H., Bonsall, D., Rogdaki, M., Shatalina, E., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14122-0 · Cited by 243 · see citing works

Clinically Relevant Doses of Methylphenidate Significantly Occupy Norepinephrine Transporters in Humans In Vivo

Hannestad, J., Gallezot, J.-D., Planeta-Wilson, B., Lin, S.-F., Williams, W. A., van Dyck, C. H., Malison, R. T., Carson, R. E., & Ding, Y.-S. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.017 · Cited by 236 · see citing works

Neuroinflammation in schizophrenia: meta-analysis of <i>in vivo</i> microglial imaging studies

Marques, T. R., Ashok, A. H., Pillinger, T., Veronese, M., Turkheimer, F. E., Dazzan, P., Sommer, I. E. C., & Howes, O. D. (2019) · Psychological Medicine · doi:10.1017/s0033291718003057 · Cited by 213 · see citing works

Mesolimbic dopamine release is linked to symptom severity in pathological gambling

Joutsa, J., Johansson, J., Niemelä, S., Ollikainen, A., Hirvonen, M. M., Piepponen, P., Arponen, E., Alho, H., Voon, V., Rinne, J. O., et al. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.02.006 · Cited by 209 · see citing works

Imaging glutamate in schizophrenia: review of findings and implications for drug discovery

Poels, E. M. P., Kegeles, L. S., Kantrowitz, J. T., Slifstein, M., Javitt, D. C., Lieberman, J. A., Abi-Dargham, A., & Girgis, R. R. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.136 · Cited by 205 · see citing works

In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [11C]-(+)-PHNO

Boileau, I., Payer, D., Chugani, B., Lobo, D. S. S., Houle, S., Wilson, A. A., Warsh, J., Kish, S. J., & Zack, M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.163 · Cited by 198 · see citing works

Striatal dopamine D2/D3 receptor binding in pathological gambling is correlated with mood-related impulsivity

Clark, L., Stokes, P. R., Wu, K., Michalczuk, R., Benecke, A., Watson, B. J., Egerton, A., Piccini, P., Nutt, D. J., Bowden-Jones, H., et al. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.06.067 · Cited by 193 · see citing works

The<scp>D</scp>_2/3dopamine receptor in pathological gambling: a positron emission tomography study with [¹¹<scp>C</scp>]‐(+)‐propyl‐hexahydro‐naphtho‐oxazin and [¹¹<scp>C</scp>]raclopride

Boileau, I., Payer, D., Chugani, B., Lobo, D., Behzadi, A., Rusjan, P. M., Houle, S., Wilson, A. A., Warsh, J., Kish, S. J., et al. (2013) · Addiction · doi:10.1111/add.12066 · Cited by 190 · see citing works

A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding

Madsen, M. K., Fisher, P. M., Stenbæk, D. S., Kristiansen, S., Burmester, D., Lehel, S., Páleníček, T., Kuchař, M., Svarer, C., Ozenne, B., et al. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.02.001 · Cited by 183 · see citing works

Test–retest measurements of dopamine D1-type receptors using simultaneous PET/MRI imaging

Kaller, S., Rullmann, M., Patt, M., Becker, G.-A., Luthardt, J., Girbardt, J., Meyer, P. M., Werner, P., Barthel, H., Bresch, A., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3645-0 · Cited by 152 · see citing works

β2-Nicotinic Acetylcholine Receptor Availability During Acute and Prolonged Abstinence From Tobacco Smoking

Cosgrove, K. P., Batis, J., Bois, F., Maciejewski, P. K., Esterlis, I., Kloczynski, T., Stiklus, S., Krishnan-Sarin, S., O’Malley, S., Perry, E., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.41 · Cited by 159 · see citing works

Amyloid Imaging With Carbon 11–Labeled Pittsburgh Compound B for Traumatic Brain Injury

Hong, Y. T., Veenith, T., Dewar, D., Outtrim, J. G., Mani, V., Williams, C., Pimlott, S., Hutchinson, P. J. A., Tavares, A., Canales, R., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.4847 · Cited by 158 · see citing works

Striatal Dopamine Transporter Availability Associated with Polymorphisms in the Dopamine Transporter Gene SLC6A3

van de Giessen, E. M., de Win, M. M. L., Tanck, M. W. T., van den Brink, W., Baas, F., & Booij, J. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.053652 · Cited by 156 · see citing works

Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [11C]ABP688 and PET imaging study in depression

Esterlis, I., DellaGioia, N., Pietrzak, R. H., Matuskey, D., Nabulsi, N., Abdallah, C. G., Yang, J., Pittenger, C., Sanacora, G., Krystal, J. H., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.58 · Cited by 148 · see citing works

Striatal dopamine transporter availability in unmedicated bipolar disorder: Striatal DAT in unmedicated bipolar disorder

Anand, A., Barkay, G., Dzemidzic, M., Albrecht, D., Karne, H., Zheng, Q.-H., Hutchins, G. D., Normandin, M. D., & Yoder, K. K. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00936.x · Cited by 139 · see citing works

Microglial activation in healthy aging

Schuitemaker, A., van der Doef, T. F., Boellaard, R., van der Flier, W. M., Yaqub, M., Windhorst, A. D., Barkhof, F., Jonker, C., Kloet, R. W., Lammertsma, A. A., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.09.016 · Cited by 142 · see citing works

Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas

Lanzenberger, R., Kranz, G. S., Haeusler, D., Akimova, E., Savli, M., Hahn, A., Mitterhauser, M., Spindelegger, C., Philippe, C., Fink, M., et al. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.07.023 · Cited by 139 · see citing works

In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings

Hall, B., Mak, E., Cervenka, S., Aigbirhio, F. I., Rowe, J. B., & O’Brien, J. T. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.03.002 · Cited by 132 · see citing works

Greater Nicotinic Acetylcholine Receptor Density in Smokers Than in Nonsmokers: A PET Study with 2-¹⁸F-FA-85380

Mukhin, A. G., Kimes, A. S., Chefer, S. I., Matochik, J. A., Contoreggi, C. S., Horti, A. G., Vaupel, D. B., Pavlova, O., & Stein, E. A. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.050716 · Cited by 135 · see citing works

Inverted-U-shaped correlation between dopamine receptor availability in striatum and sensation seeking

Gjedde, A., Kumakura, Y., Cumming, P., Linnet, J., & Møller, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912319107 · Cited by 130 · see citing works

Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys

Hashimoto, K., Kakiuchi, T., Ohba, H., Nishiyama, S., & Tsukada, H. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0692-7 · Cited by 127 · see citing works

Positron Emission Tomography Quantification of Serotonin_1AReceptor Binding in Suicide Attempters With Major Depressive Disorder

Sullivan, G. M., Oquendo, M. A., Milak, M., Miller, J. M., Burke, A., Ogden, R. T., Parsey, R. V., & Mann, J. J. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2406 · Cited by 118 · see citing works

Neural mechanisms underlying heterogeneity in the presentation of anxious temperament

Shackman, A. J., Fox, A. S., Oler, J. A., Shelton, S. E., Davidson, R. J., & Kalin, N. H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214364110 · Cited by 113 · see citing works

History of childhood adversity is positively associated with ventral striatal dopamine responses to amphetamine

Oswald, L. M., Wand, G. S., Kuwabara, H., Wong, D. F., Zhu, S., & Brasic, J. R. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3407-z · Cited by 114 · see citing works

Psychosocial stress is associated with in vivo dopamine release in human ventromedial prefrontal cortex: A positron emission tomography study using [18F]fallypride

Lataster, J., Collip, D., Ceccarini, J., Haas, D., Booij, L., van Os, J., Pruessner, J., Van Laere, K., & Myin-Germeys, I. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.07.030 · Cited by 109 · see citing works

Positron Emission Tomography Quantification of Serotonin Transporter in Suicide Attempters with Major Depressive Disorder

Miller, J. M., Hesselgrave, N., Ogden, R. T., Sullivan, G. M., Oquendo, M. A., Mann, J. J., & Parsey, R. V. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.024 · Cited by 102 · see citing works

In vivo evidence of lower synaptic vesicle density in schizophrenia

Radhakrishnan, R., Skosnik, P. D., Ranganathan, M., Naganawa, M., Toyonaga, T., Finnema, S., Hillmer, A. T., Esterlis, I., Huang, Y., Nabulsi, N., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01184-0 · Cited by 100 · see citing works

Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application

Watkins, C. C., Sawa, A., & Pomper, M. G. (2014) · Translational Psychiatry · doi:10.1038/tp.2013.119 · Cited by 100 · see citing works

Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer disease

Reeves, S., Brown, R., Howard, R., & Grasby, P. (2009) · Neurology · doi:10.1212/01.wnl.0000341932.21961.f3 · Cited by 98 · see citing works

Positron Emission Tomographic Imaging of the Serotonergic System and Prediction of Risk and Lethality of Future Suicidal Behavior

Oquendo, M. A., Galfalvy, H., Sullivan, G. M., Miller, J. M., Milak, M. M., Sublette, M. E., Cisneros-Trujillo, S., Burke, A. K., Parsey, R. V., & Mann, J. J. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.1478 · Cited by 93 · see citing works

Cocaine cue-induced dopamine release in amygdala and hippocampus: a high-resolution PET [18F]fallypride study in cocaine dependent participants

Fotros, A., Casey, K. F., Larcher, K., Verhaeghe, J. A., Cox, S. M., Gravel, P., Reader, A. J., Dagher, A., Benkelfat, C., & Leyton, M. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.77 · Cited by 89 · see citing works

D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: a PET study in a receptor internalization-deficient mouse model

Skinbjerg, M., Liow, J.-S., Seneca, N., Hong, J., Lu, S., Thorsell, A., Heilig, M., Pike, V. W., Halldin, C., Sibley, D. R., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.01.055 · Cited by 86 · see citing works

Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [¹¹C]UCB‐J positron emission tomography study

Finnema, S. J., Toyonaga, T., Detyniecki, K., Chen, M., Dias, M., Wang, Q., Lin, S., Naganawa, M., Gallezot, J., Lu, Y., et al. (2020) · Epilepsia · doi:10.1111/epi.16653 · Cited by 78 · see citing works

In Vivo TSPO Signal and Neuroinflammation in Alzheimer’s Disease

Tournier, B. B., Tsartsalis, S., Ceyzériat, K., Garibotto, V., & Millet, P. (2020) · Cells · doi:10.3390/cells9091941 · Cited by 79 · see citing works

Evidence Why Paroxetine Dose Escalation is Not Effective in Major Depressive Disorder: A Randomized Controlled Trial With Assessment of Serotonin Transporter Occupancy

Ruhé, H. G., Booij, J., Weert, H. C. V., Reitsma, J. B., Fransen, E. J. F., Michel, M. C., & Schene, A. H. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.148 · Cited by 73 · see citing works

Attenuated serotonin transporter association between dorsal raphe and ventral striatum in major depression

Hahn, A., Haeusler, D., Kraus, C., Höflich, A. S., Kranz, G. S., Baldinger, P., Savli, M., Mitterhauser, M., Wadsak, W., Karanikas, G., et al. (2014) · Human Brain Mapping · doi:10.1002/hbm.22442 · Cited by 66 · see citing works

Evidence for coordinated functional activity within the extended amygdala of non-human and human primates

Oler, J. A., Birn, R. M., Patriat, R., Fox, A. S., Shelton, S. E., Burghy, C. A., Stodola, D. E., Essex, M. J., Davidson, R. J., & Kalin, N. H. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.03.045 · Cited by 67 · see citing works

Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies

Ratti, E., Bettica, P., Alexander, R., Archer, G., Carpenter, D., Evoniuk, G., Gomeni, R., Lawson, E., Lopez, M., Millns, H., et al. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113480990 · Cited by 69 · see citing works

Regional differences in SERT occupancy after acute and prolonged SSRI intake investigated by brain PET

Baldinger, P., Kranz, G. S., Haeusler, D., Savli, M., Spies, M., Philippe, C., Hahn, A., Höflich, A., Wadsak, W., Mitterhauser, M., et al. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2013.10.002 · Cited by 67 · see citing works

Impaired prefrontal cortical dopamine release in schizophrenia during a cognitive task: A [11C]FLB 457 positron emission tomography study

Rao, N., Northoff, G., Tagore, A., Rusjan, P., Kenk, M., Wilson, A., Houle, S., Strafella, A., Remington, G., & Mizrahi, R. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby076 · Cited by 67 · see citing works

Central amygdala nucleus (Ce) gene expression linked to increased trait-like Ce metabolism and anxious temperament in young primates

Fox, A. S., Oler, J. A., Shelton, S. E., Nanda, S. A., Davidson, R. J., Roseboom, P. H., & Kalin, N. H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206723109 · Cited by 57 · see citing works

Synthesis and in vivo evaluation of [18F]UCB-J for PET imaging of synaptic vesicle glycoprotein 2A (SV2A)

Li, S., Cai, Z., Zhang, W., Holden, D., Lin, S.-F., Finnema, S. J., Shirali, A., Ropchan, J., Carre, S., Mercier, J., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04357-w · Cited by 59 · see citing works

History of cannabis use is not associated with alterations in striatal dopamine D ₂ /D ₃ receptor availability

Stokes, P. R., Egerton, A., Watson, B., Reid, A., Lappin, J., Howes, O. D., Nutt, D. J., & Lingford-Hughes, A. R. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111414090 · Cited by 63 · see citing works

Striatal dopamine transporter binding correlates with serum BDNF levels in patients with striatal dopaminergic neurodegeneration

Ziebell, M., Khalid, U., Klein, A. B., Aznar, S., Thomsen, G., Jensen, P., & Knudsen, G. M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.11.010 · Cited by 62 · see citing works

The Norepinephrine Transporter in Attention-Deficit/Hyperactivity Disorder Investigated With Positron Emission Tomography

Vanicek, T., Spies, M., Rami-Mark, C., Savli, M., Höflich, A., Kranz, G. S., Hahn, A., Kutzelnigg, A., Traub-Weidinger, T., Mitterhauser, M., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1226 · Cited by 61 · see citing works

Elevated Dopamine D2/3 Receptor Availability in Obese Individuals: A PET Imaging Study with [11C](+)PHNO

Gaiser, E. C., Gallezot, J.-D., Worhunsky, P. D., Jastreboff, A. M., Pittman, B., Kantrovitz, L., Angarita, G. A., Cosgrove, K. P., Potenza, M. N., Malison, R. T., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.115 · Cited by 59 · see citing works

Preliminary in vivo evidence of lower hippocampal synaptic density in cannabis use disorder

D’Souza, D. C., Radhakrishnan, R., Naganawa, M., Ganesh, S., Nabulsi, N., Najafzadeh, S., Ropchan, J., Ranganathan, M., Cortes-Briones, J., Huang, Y., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00891-4 · Cited by 55 · see citing works

Baseline-dependent effects of cocaine pre-exposure on impulsivity and D2/3 receptor availability in the rat striatum: possible relevance to the attention-deficit hyperactivity syndrome

Caprioli, D., Hong, Y. T., Sawiak, S. J., Ferrari, V., Williamson, D. J., Jupp, B., Adrian Carpenter, T., Aigbirhio, F. I., Everitt, B. J., Robbins, T. W., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.44 · Cited by 58 · see citing works

Cocaine cue-induced dopamine release in the human prefrontal cortex

Milella, M. S., Fotros, A., Gravel, P., Casey, K. F., Larcher, K., Verhaeghe, J. A. J., Cox, S. M. L., Reader, A. J., Dagher, A., Benkelfat, C., et al. (2016) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.150207 · Cited by 56 · see citing works

Linking dopaminergic reward signals to the development of attentional bias: A positron emission tomographic study

Anderson, B. A., Kuwabara, H., Wong, D. F., Roberts, J., Rahmim, A., Brašić, J. R., & Courtney, S. M. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.05.062 · Cited by 55 · see citing works

Validation and noninvasive kinetic modeling of [ ¹¹ C]UCB-J PET imaging in mice

Bertoglio, D., Verhaeghe, J., Miranda, A., Kertesz, I., Cybulska, K., Korat, Š., Wyffels, L., Stroobants, S., Mrzljak, L., Dominguez, C., et al. (2020) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1177/0271678x19864081 · Cited by 54 · see citing works

In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers

Narendran, R., Lopresti, B. J., Martinez, D., Mason, N. S., Himes, M., May, M. A., Daley, D. C., Price, J. C., Mathis, C. A., & Frankle, W. G. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11010126 · Cited by 53 · see citing works

Characterisation of partial volume effect and region-based correction in small animal positron emission tomography (PET) of the rat brain

Lehnert, W., Gregoire, M.-C., Reilhac, A., & Meikle, S. R. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.02.032 · Cited by 52 · see citing works

Positron emission tomography imaging using an inverse agonist radioligand to assess cannabinoid CB1 receptors in rodents

Terry, G., Liow, J.-S., Chernet, E., Zoghbi, S. S., Phebus, L., Felder, C. C., Tauscher, J., Schaus, J. M., Pike, V. W., Halldin, C., et al. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.03.004 · Cited by 51 · see citing works

Amphetamine-induced dopamine release and neurocognitive function in treatment-naive adults with ADHD

Cherkasova, M. V., Faridi, N., Casey, K. F., O'Driscoll, G. A., Hechtman, L., Joober, R., Baker, G. B., Palmer, J., Dagher, A., Leyton, M., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.349 · Cited by 49 · see citing works

Honesty mediates the relationship between serotonin and reaction to unfairness

Takahashi, H., Takano, H., Camerer, C. F., Ideno, T., Okubo, S., Matsui, H., Tamari, Y., Takemura, K., Arakawa, R., Kodaka, F., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118687109 · Cited by 47 · see citing works

Resting-state synchrony between the retrosplenial cortex and anterior medial cortical structures relates to memory complaints in subjective cognitive impairment

Yasuno, F., Kazui, H., Yamamoto, A., Morita, N., Kajimoto, K., Ihara, M., Taguchi, A., Matsuoka, K., Kosaka, J., Tanaka, T., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.03.006 · Cited by 44 · see citing works

Risky decision-making and ventral striatal dopamine responses to amphetamine: A positron emission tomography [11C]raclopride study in healthy adults

Oswald, L. M., Wand, G. S., Wong, D. F., Brown, C. H., Kuwabara, H., & Brašić, J. R. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.03.022 · Cited by 45 · see citing works

Equivalent Dynamic Human Brain NK1-Receptor Occupancy Following Single-Dose i.v. Fosaprepitant vs. Oral Aprepitant as Assessed by PET Imaging

Van Laere, K., De Hoon, J., Bormans, G., Koole, M., Derdelinckx, I., De Lepeleire, I., Declercq, R., Sanabria Bohorquez, S. M., Hamill, T., Mozley, P. D., et al. (2012) · Clinical Pharmacology &amp; Therapeutics · doi:10.1038/clpt.2012.62 · Cited by 46 · see citing works

Dopamine release in nucleus accumbens during rewarded task switching measured by [¹¹C]raclopride

Jonasson, L. S., Axelsson, J., Riklund, K., Braver, T. S., Ögren, M., Bäckman, L., & Nyberg, L. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.05.047 · Cited by 42 · see citing works

Lower prefrontal cortical synaptic vesicle binding in cocaine use disorder: An exploratory ¹¹ C‐UCB‐J positron emission tomography study in humans

Angarita, G. A., Worhunsky, P. D., Naganawa, M., Toyonaga, T., Nabulsi, N. B., Li, C. R., Esterlis, I., Skosnik, P. D., Radhakrishnan, R., Pittman, B., et al. (2022) · Addiction Biology · doi:10.1111/adb.13123 · Cited by 38 · see citing works

Cognitive Function and Monoamine Neurotransmission in Schizophrenia: Evidence From Positron Emission Tomography Studies

Takano, H. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00228 · Cited by 34 · see citing works

Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission Tomography

Spies, M., James, G. M., Berroterán-Infante, N., Ibeschitz, H., Kranz, G. S., Unterholzner, J., Godbersen, M., Gryglewski, G., Hienert, M., Jungwirth, J., et al. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx085 · Cited by 34 · see citing works

Synaptic changes in psychiatric and neurological disorders: State-of-the art of in vivo imaging

Howes, O., Marcinkowska, J., Turkheimer, F. E., & Carr, R. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-024-01943-x · Cited by 34 · see citing works

Nigral stress-induced dopamine release in clinical high risk and antipsychotic-naïve schizophrenia

Tseng, H.-H., Watts, J. J., Kiang, M., Suridjan, I., Wilson, A. A., Houle, S., Rusjan, P. M., & Mizrahi, R. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx042 · Cited by 31 · see citing works

Presynaptic Serotoninergic Regulation of Emotional Processing: A Multimodal Brain Imaging Study

Selvaraj, S., Mouchlianitis, E., Faulkner, P., Turkheimer, F., Cowen, P. J., Roiser, J. P., & Howes, O. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.04.011 · Cited by 29 · see citing works

Molecular Neurobiology of Depression: PET Findings on the Elusive Correlation with Symptom Severity

Smith, D. F., & Jakobsen, S. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00008 · Cited by 25 · see citing works

In vivo imaging of synaptic density with [11C]UCB-J PET in two mouse models of neurodegenerative disease

Xiong, M., Roshanbin, S., Rokka, J., Schlein, E., Ingelsson, M., Sehlin, D., Eriksson, J., & Syvänen, S. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118302 · Cited by 24 · see citing works

Positron Emission Tomography Study of the Effects of Tryptophan Depletion on Brain Serotonin₂Receptors in Subjects Recently Remitted From Major Depression

Yatham, L. N., Liddle, P. F., Sossi, V., Erez, J., Vafai, N., Lam, R. W., & Blinder, S. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1493 · Cited by 24 · see citing works

Effects of the sigma-1 receptor agonist blarcamesine in a murine model of fragile X syndrome: neurobehavioral phenotypes and receptor occupancy

Reyes, S. T., Deacon, R. M. J., Guo, S. G., Altimiras, F. J., Castillo, J. B., van der Wildt, B., Morales, A. P., Park, J. H., Klamer, D., Rosenberg, J., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-94079-7 · Cited by 22 · see citing works

Occupancy of serotonin transporters in the amygdala by paroxetine in association with attenuation of left amygdala activation by negative faces in major depressive disorder

Ruhé, H. G., Koster, M., Booij, J., van Herk, M., Veltman, D. J., & Schene, A. H. (2014) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2013.12.003 · Cited by 20 · see citing works

Time-course of serotonin transporter occupancy by single dose of three SSRIs in human brain: A positron emission tomography study with [11C]DASB

Arakawa, R., Tateno, A., Kim, W., Sakayori, T., Ogawa, K., & Okubo, Y. (2016) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2016.03.006 · Cited by 16 · see citing works

Glucose sensing mediated by portal glucagon-like peptide 1 receptor is markedly impaired in insulin-resistant obese animals

Malbert, C.-H., Chauvin, A., Horowitz, M., & Jones, K. L. (2021) · Diabetes · doi:10.2337/db20-0361 · Cited by 18 · see citing works

Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression

Asch, R. H., Abdallah, C. G., Carson, R. E., & Esterlis, I. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-024-01913-3 · Cited by 13 · see citing works

Maternal dopamine encodes affective signals of human infants

Zeevi, L., Irani, M., Catana, C., Feldman Barrett, L., & Atzil, S. (2022) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsab116 · Cited by 12 · see citing works

Increased binding of 5-HT1A receptors in a dissociative amnesic patient after the recovery process

Kitamura, S., Yasuno, F., Inoue, M., Kosaka, J., Kiuchi, K., Matsuoka, K., Kishimoto, T., & Suhara, T. (2014) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2014.07.001 · Cited by 9 · see citing works

An open‐label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (<i>R</i>)‐(–)‐<i>O</i>‐desmethylvenlafaxine and racemic <i>O</i>‐desmethylvenlafaxine

Frankle, W. G., Robertson, B., Maier, G., Paris, J., Asmonga, D., May, M., Himes, M. L., Mason, N. S., Mathis, C. A., & Narendran, R. (2018) · Synapse · doi:10.1002/syn.22021 · Cited by 6 · see citing works

Dopamine Type 2/3 Receptor Availability in the Striatum and Social Status in Human Volunteers

Martinez, D., Orlowska, D., Narendran, R., Slifstein, M., Liu, F., Kumar, D., Broft, A., Van Heertum, R., & Kleber, H. D. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.07.037 · Cited by 146 · see citing works

Quantitative monitoring of ketamine’s impact on synaptic density using 11C-UCB-J PET imaging in the corticosterone mouse model of anxiety/depression

Corvo, C., Goutal, S., Mendez-David, I., Leterrier, S., Caille, F., Saba, W., Colle, R., Corruble, E., Lebon, V., Bottlaender, M., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-025-03369-3 · Cited by 1 · see citing works